BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37407632)

  • 21. Effect of extremely low frequency electromagnetic field parameters on the proliferation of human breast cancer.
    Wang MH; Chen KW; Ni DX; Fang HJ; Jang LS; Chen CH
    Electromagn Biol Med; 2021 Jul; 40(3):384-392. PubMed ID: 33632057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase.
    Li W; Liu J; Fu W; Zheng X; Ren L; Liu S; Wang J; Ji T; Du G
    J Exp Clin Cancer Res; 2018 Jul; 37(1):132. PubMed ID: 29970196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced cytotoxic and genotoxic effects of gadolinium following ELF-EMF irradiation in human lymphocytes.
    Cho S; Lee Y; Lee S; Choi YJ; Chung HW
    Drug Chem Toxicol; 2014 Oct; 37(4):440-7. PubMed ID: 24479558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extremely low frequency variable electromagnetic fields affect cancer and noncancerous cells in vitro differently: Preliminary study.
    Koziorowska A; Romerowicz-Misielak M; Sołek P; Koziorowski M
    Electromagn Biol Med; 2018; 37(1):35-42. PubMed ID: 29513614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Influence of the Extremely Low Frequency Electromagnetic Field on Clear Cell Renal Carcinoma.
    Cios A; Ciepielak M; Stankiewicz W; Szymański Ł
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Andrographolide Induces G2/M Cell Cycle Arrest and Apoptosis in Human Glioblastoma DBTRG-05MG Cell Line via ERK1/2 /c-Myc/p53 Signaling Pathway.
    Othman NS; Mohd Azman DK
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell type specific redox status is responsible for diverse electromagnetic field effects.
    Simkó M
    Curr Med Chem; 2007; 14(10):1141-52. PubMed ID: 17456027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells.
    Hirose Y; Berger MS; Pieper RO
    Cancer Res; 2001 Mar; 61(5):1957-63. PubMed ID: 11280752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Long Form of CAPON Overexpression on Glioma Cell Proliferation are Dependent on AKT/mTOR/P53 Signaling.
    Liang D; Song Y; Fan G; Ji D; Zhang T; Nie E; Liu X; Liang J; Yu R; Gao S
    Int J Med Sci; 2019; 16(4):614-622. PubMed ID: 31171914
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of ketamine administration on chronic unpredictable stress-induced rat model of depression during extremely low-frequency electromagnetic field exposure: Behavioral, histological and molecular study.
    Salari M; Eftekhar-Vaghefi SH; Asadi-Shekaari M; Esmaeilpour K; Solhjou S; Amiri M; Ahmadi-Zeidabadi M
    Brain Behav; 2023 May; 13(5):e2986. PubMed ID: 37032465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hairless regulates p53 target genes to exert tumor suppressive functions in glioblastoma.
    Brook L; Palade P; Maatough A; Whitfield GK; Emeterio LS; Hsieh D; Hsieh JC
    J Cell Biochem; 2019 Jan; 120(1):533-543. PubMed ID: 30191601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 status.
    Patyka M; Sharifi Z; Petrecca K; Mansure J; Jean-Claude B; Sabri S
    Oncotarget; 2016 Sep; 7(37):60245-60269. PubMed ID: 27533246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coupling of oxidative stress responses to tricarboxylic acid cycle and prostaglandin E
    Sun Y; Shi Z; Wang Y; Tang C; Liao Y; Yang C; Cai P
    Int J Radiat Biol; 2018 Dec; 94(12):1159-1166. PubMed ID: 30307357
    [No Abstract]   [Full Text] [Related]  

  • 34. Extremely low frequency electromagnetic fields modulate expression of inducible nitric oxide synthase, endothelial nitric oxide synthase and cyclooxygenase-2 in the human keratinocyte cell line HaCat: potential therapeutic effects in wound healing.
    Patruno A; Amerio P; Pesce M; Vianale G; Di Luzio S; Tulli A; Franceschelli S; Grilli A; Muraro R; Reale M
    Br J Dermatol; 2010 Feb; 162(2):258-66. PubMed ID: 19799606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extremely low-frequency electromagnetic fields accelerates wound healing modulating MMP-9 and inflammatory cytokines.
    Patruno A; Ferrone A; Costantini E; Franceschelli S; Pesce M; Speranza L; Amerio P; D'Angelo C; Felaco M; Grilli A; Reale M
    Cell Prolif; 2018 Apr; 51(2):e12432. PubMed ID: 29357406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights in the biology of extremely low-frequency magnetic fields exposure on human health.
    Karimi A; Ghadiri Moghaddam F; Valipour M
    Mol Biol Rep; 2020 Jul; 47(7):5621-5633. PubMed ID: 32515000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exposure of rats to extremely low-frequency electromagnetic fields (ELF-EMF) alters cytokines production.
    Salehi I; Sani KG; Zamani A
    Electromagn Biol Med; 2013 Mar; 32(1):1-8. PubMed ID: 23046051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the genotoxic effects induced by 50 Hz extremely low-frequency electromagnetic fields and 1800 MHz radiofrequency electromagnetic fields in GC-2 cells.
    Duan W; Liu C; Zhang L; He M; Xu S; Chen C; Pi H; Gao P; Zhang Y; Zhong M; Yu Z; Zhou Z
    Radiat Res; 2015 Mar; 183(3):305-14. PubMed ID: 25688995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extremely low-frequency electromagnetic fields induce neural differentiation in bone marrow derived mesenchymal stem cells.
    Kim HJ; Jung J; Park JH; Kim JH; Ko KN; Kim CW
    Exp Biol Med (Maywood); 2013 Aug; 238(8):923-31. PubMed ID: 23970408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electromagnetic fields affect transcript levels of apoptosis-related genes in embryonic stem cell-derived neural progenitor cells.
    Nikolova T; Czyz J; Rolletschek A; Blyszczuk P; Fuchs J; Jovtchev G; Schuderer J; Kuster N; Wobus AM
    FASEB J; 2005 Oct; 19(12):1686-8. PubMed ID: 16116041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.